Live Breaking News & Updates on தாக்கல் க்கு திவால்நிலை|Page 6
Stay updated with breaking news from தாக்கல் க்கு திவால்நிலை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vancouver, British Columbia (Newsfile Corp. - April 12, 2021) - Daura Capital Corp. (TSXV: DUR.P) (the "Company" or "Daura"), a capital pool company under the policies of the TSX Venture Exchange (the ....
04 Apr 2021 - 15:35 The ByteDance logo is seen in this illustration taken, Nov. 27, 2019. REUTERS/Dado Ruvic/Illustration/File Photo Reuters Mumbai: China s ByteDance has told an Indian court that a government freeze on its bank accounts in a probe of possible tax evasion amounts to harassment and was done illegally, according to a filing seen by Reuters. ByteDance in January reduced its Indian workforce after New Delhi maintained a ban on its popular video app TikTok, imposed last year after a border clash between India and China. Beijing has repeatedly criticised India over that ban and those of other Chinese apps. ....
Mindset Pharma Inc.: Mindset Pharma Announces Filing of Amended and Restated FS and MD&A for the Three and Six Month Period Ended December 31, 2020 Mindset Pharma Inc. (CSE: MSET) (OTCQB: MSSTF) (FSE: 9DF) ( Mindset or the Company ) - Mindset announces that it has refiled its interim financial statements for the three and six month period ended December 31, 2020 (the Financial Statements ) and accompanying management discussion and analysis (the MD&A ) as they have been restated to reflect certain adjustments resulting from a review by the Company s auditors. The following adjustments were made to the restated unaudited interim condensed consolidated financial statements: ....
Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Filing of 2020 Year-End Financial Statements and MD&A Cardiol Therapeutics Inc. ( a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, today filed its audited Financial Statements and Management s Discussion and Analysis for the year ended December 31, 2020. Both are available under the Company s profile on SEDAR at www.sedar.com and on the Company s website at www.cardiolrx.com. David Elsley, President and Chief Executive Officer of Cardiol, commented: 2020 was a very exciting year for Cardiol Therapeutics. We made extraordinary progress in our research and clinical development programs, while significantly strengthening our financial position. We are particularly excited about the progress made across our research and development programs supporting the development of CardiolRx, our pharmaceutically produced extra- ....